Optimize Trial Design with Biosimulation
Questions Biosimulation Can Answer
- Who has the right phenotype to be included in the trial?
- What are the best dosing and monitoring schedules for Phase 2 and 3?
- How many dosing arms are needed?
- Which biomarkers identify early success and risk of adverse events?
- When is the right time to end a clinical trial?
- How does the drug candidate or target translate to different global markets?
http://sildenafil50mg100mg.accountant sildenafil 100mg